ADENOCARCINOMA METASTATIC

This adverse event was reported 206 times

These drugs are most commonly taken by patients reporting ADENOCARCINOMA METASTATIC:

# Drug Count
0 BEVACIZUMAB 35
1 OXALIPLATIN 26
2 PACLITAXEL 25
3 PACLITAXEL (AIBUMIN-BOUND) 25
4 CARBOPLATIN 23
5 CAPECITABINE 22
6 FLUOROURACIL 22
7 FLUOROURACIL CREAM, 0.5% 22
8 TRASTUZUMAB 22
9 PREDNISONE 16
See all common drugs associated with ADENOCARCINOMA METASTATIC

ADENOCARCINOMA METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PLATINUM 1 0.0019
1 SORBITOL 1 0.0017
2 CAPIVASERTIB 5 0.0016
3 EPOETIN ALFA-EPBX 3 0.0013
4 RAMUCIRUMAB 8 0.0013
5 CERITINIB 3 0.0013
6 LISOCABTAGENE MARALEUCEL 1 0.0011
7 PANITUMUMAB 15 0.0009
8 IMIQUIMOD 2 0.0009
9 PIOGLITAZONE HYDROCHLORIDE 1 0.0008
See all drugs enriched for association with ADENOCARCINOMA METASTATIC